NCT01122498 - A Safety Study Of BMP-655/ACS As An Adjuvant Therapy For Treatment Of Rotator Cuff Tears | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Rotator Cuff Tear

Interventions

BIOLOGICAL

BMP-655/ACS+Standard of care or Standard of care

BMP-655/ACS 0.015mg/mL

BIOLOGICAL

BMP-655/ACS+Standard of care or Standard of care

BMP-655/ACS 0.05mg/mL

BIOLOGICAL

BMP-655/ACS+Standard of care or Standard of care

BMP-655/ACS 0.15mg/mL or 0.025mg/mL

Trial Locations (9)

Pfizer Investigational Site, Chikushino-shi

Pfizer Investigational Site, Kure

Pfizer Investigational Site, Koushi

Pfizer Investigational Site, Kumamoto

Pfizer Investigational Site, Toyonaka

Pfizer Investigational Site, Hiroshima

Pfizer Investigational Site, Kanagawa

Pfizer Investigational Site, Kumamoto

Pfizer Investigational Site, Nagano